The global Automated Needle Targeting (ANT) market size was valued at US$ 2286.6 million in 2023. With growing demand in downstream market, the Automated Needle Targeting (ANT) is forecast to a readjusted size of US$ 3460.9 million by 2030 with a CAGR of 6.1% during review period.
The research report highlights the growth potential of the global Automated Needle Targeting (ANT) market. Automated Needle Targeting (ANT) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Automated Needle Targeting (ANT). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Automated Needle Targeting (ANT) market.
ANT analyzes the X-ray or CT images, generates 2D (X-ray) or 3D (CT) models, and the puncture path was automatically calculated and transformed to motion parameters for the puncture robot through the artificial intelligence (AI) algorithms, thereby assisting doctors with accurate biopsies.
Increasing demand for minimally invasive procedures: Minimally invasive procedures offer advantages such as shorter hospital stays, faster recovery times, and reduced complications. ANT systems enable healthcare providers to perform these procedures with greater precision, making them more attractive to both patients and healthcare professionals.
Technological advancements: ANT systems continue to benefit from advancements in imaging technologies, such as ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT). These technologies provide real-time, high-resolution imaging, allowing for more accurate needle targeting and placement.
Rising prevalence of chronic diseases: The growing prevalence of chronic diseases like cancer and cardiovascular disorders has led to an increased demand for diagnostic and therapeutic procedures. ANT systems can aid in the precise targeting of tumors, lesions, and other affected areas, improving the effectiveness of treatments.
Improved patient outcomes: The use of ANT systems can reduce the risk of complications associated with needle-based procedures, such as organ damage or bleeding. By improving accuracy and reducing errors, these systems contribute to better patient outcomes and overall satisfaction.
Key Features:
The report on Automated Needle Targeting (ANT) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Automated Needle Targeting (ANT) market. It may include historical data, market segmentation by Type (e.g., Percutaneous Lung Biopsy, Percutaneous Nephrolithotomy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Automated Needle Targeting (ANT) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Automated Needle Targeting (ANT) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Automated Needle Targeting (ANT) industry. This include advancements in Automated Needle Targeting (ANT) technology, Automated Needle Targeting (ANT) new entrants, Automated Needle Targeting (ANT) new investment, and other innovations that are shaping the future of Automated Needle Targeting (ANT).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Automated Needle Targeting (ANT) market. It includes factors influencing customer ' purchasing decisions, preferences for Automated Needle Targeting (ANT) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Automated Needle Targeting (ANT) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Automated Needle Targeting (ANT) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Automated Needle Targeting (ANT) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Automated Needle Targeting (ANT) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Automated Needle Targeting (ANT) market.
Market Segmentation:
Automated Needle Targeting (ANT) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Percutaneous Lung Biopsy
Percutaneous Nephrolithotomy
Segmentation by application
Hospitals
Ambulatory Surgical Center
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
NDR Medical
Microport
Zimmer Biomet
Smith & Nephew
Cgbio Inc.
Fraunhofer IPA
Key Questions Addressed in this Report
What is the 10-year outlook for the global Automated Needle Targeting (ANT) market?
What factors are driving Automated Needle Targeting (ANT) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Automated Needle Targeting (ANT) market opportunities vary by end market size?
How does Automated Needle Targeting (ANT) break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Automated Needle Targeting (ANT) Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Automated Needle Targeting (ANT) by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Automated Needle Targeting (ANT) by Country/Region, 2019, 2023 & 2030
2.2 Automated Needle Targeting (ANT) Segment by Type
2.2.1 Percutaneous Lung Biopsy
2.2.2 Percutaneous Nephrolithotomy
2.3 Automated Needle Targeting (ANT) Sales by Type
2.3.1 Global Automated Needle Targeting (ANT) Sales Market Share by Type (2019-2024)
2.3.2 Global Automated Needle Targeting (ANT) Revenue and Market Share by Type (2019-2024)
2.3.3 Global Automated Needle Targeting (ANT) Sale Price by Type (2019-2024)
2.4 Automated Needle Targeting (ANT) Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Center
2.4.3 Others
2.5 Automated Needle Targeting (ANT) Sales by Application
2.5.1 Global Automated Needle Targeting (ANT) Sale Market Share by Application (2019-2024)
2.5.2 Global Automated Needle Targeting (ANT) Revenue and Market Share by Application (2019-2024)
2.5.3 Global Automated Needle Targeting (ANT) Sale Price by Application (2019-2024)
3 Global Automated Needle Targeting (ANT) by Company
3.1 Global Automated Needle Targeting (ANT) Breakdown Data by Company
3.1.1 Global Automated Needle Targeting (ANT) Annual Sales by Company (2019-2024)
3.1.2 Global Automated Needle Targeting (ANT) Sales Market Share by Company (2019-2024)
3.2 Global Automated Needle Targeting (ANT) Annual Revenue by Company (2019-2024)
3.2.1 Global Automated Needle Targeting (ANT) Revenue by Company (2019-2024)
3.2.2 Global Automated Needle Targeting (ANT) Revenue Market Share by Company (2019-2024)
3.3 Global Automated Needle Targeting (ANT) Sale Price by Company
3.4 Key Manufacturers Automated Needle Targeting (ANT) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Automated Needle Targeting (ANT) Product Location Distribution
3.4.2 Players Automated Needle Targeting (ANT) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Automated Needle Targeting (ANT) by Geographic Region
4.1 World Historic Automated Needle Targeting (ANT) Market Size by Geographic Region (2019-2024)
4.1.1 Global Automated Needle Targeting (ANT) Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Automated Needle Targeting (ANT) Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Automated Needle Targeting (ANT) Market Size by Country/Region (2019-2024)
4.2.1 Global Automated Needle Targeting (ANT) Annual Sales by Country/Region (2019-2024)
4.2.2 Global Automated Needle Targeting (ANT) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Automated Needle Targeting (ANT) Sales Growth
4.4 APAC Automated Needle Targeting (ANT) Sales Growth
4.5 Europe Automated Needle Targeting (ANT) Sales Growth
4.6 Middle East & Africa Automated Needle Targeting (ANT) Sales Growth
5 Americas
5.1 Americas Automated Needle Targeting (ANT) Sales by Country
5.1.1 Americas Automated Needle Targeting (ANT) Sales by Country (2019-2024)
5.1.2 Americas Automated Needle Targeting (ANT) Revenue by Country (2019-2024)
5.2 Americas Automated Needle Targeting (ANT) Sales by Type
5.3 Americas Automated Needle Targeting (ANT) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Automated Needle Targeting (ANT) Sales by Region
6.1.1 APAC Automated Needle Targeting (ANT) Sales by Region (2019-2024)
6.1.2 APAC Automated Needle Targeting (ANT) Revenue by Region (2019-2024)
6.2 APAC Automated Needle Targeting (ANT) Sales by Type
6.3 APAC Automated Needle Targeting (ANT) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Automated Needle Targeting (ANT) by Country
7.1.1 Europe Automated Needle Targeting (ANT) Sales by Country (2019-2024)
7.1.2 Europe Automated Needle Targeting (ANT) Revenue by Country (2019-2024)
7.2 Europe Automated Needle Targeting (ANT) Sales by Type
7.3 Europe Automated Needle Targeting (ANT) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Automated Needle Targeting (ANT) by Country
8.1.1 Middle East & Africa Automated Needle Targeting (ANT) Sales by Country (2019-2024)
8.1.2 Middle East & Africa Automated Needle Targeting (ANT) Revenue by Country (2019-2024)
8.2 Middle East & Africa Automated Needle Targeting (ANT) Sales by Type
8.3 Middle East & Africa Automated Needle Targeting (ANT) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Automated Needle Targeting (ANT)
10.3 Manufacturing Process Analysis of Automated Needle Targeting (ANT)
10.4 Industry Chain Structure of Automated Needle Targeting (ANT)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Automated Needle Targeting (ANT) Distributors
11.3 Automated Needle Targeting (ANT) Customer
12 World Forecast Review for Automated Needle Targeting (ANT) by Geographic Region
12.1 Global Automated Needle Targeting (ANT) Market Size Forecast by Region
12.1.1 Global Automated Needle Targeting (ANT) Forecast by Region (2025-2030)
12.1.2 Global Automated Needle Targeting (ANT) Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Automated Needle Targeting (ANT) Forecast by Type
12.7 Global Automated Needle Targeting (ANT) Forecast by Application
13 Key Players Analysis
13.1 NDR Medical
13.1.1 NDR Medical Company Information
13.1.2 NDR Medical Automated Needle Targeting (ANT) Product Portfolios and Specifications
13.1.3 NDR Medical Automated Needle Targeting (ANT) Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 NDR Medical Main Business Overview
13.1.5 NDR Medical Latest Developments
13.2 Microport
13.2.1 Microport Company Information
13.2.2 Microport Automated Needle Targeting (ANT) Product Portfolios and Specifications
13.2.3 Microport Automated Needle Targeting (ANT) Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Microport Main Business Overview
13.2.5 Microport Latest Developments
13.3 Zimmer Biomet
13.3.1 Zimmer Biomet Company Information
13.3.2 Zimmer Biomet Automated Needle Targeting (ANT) Product Portfolios and Specifications
13.3.3 Zimmer Biomet Automated Needle Targeting (ANT) Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Zimmer Biomet Main Business Overview
13.3.5 Zimmer Biomet Latest Developments
13.4 Smith & Nephew
13.4.1 Smith & Nephew Company Information
13.4.2 Smith & Nephew Automated Needle Targeting (ANT) Product Portfolios and Specifications
13.4.3 Smith & Nephew Automated Needle Targeting (ANT) Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Smith & Nephew Main Business Overview
13.4.5 Smith & Nephew Latest Developments
13.5 Cgbio Inc.
13.5.1 Cgbio Inc. Company Information
13.5.2 Cgbio Inc. Automated Needle Targeting (ANT) Product Portfolios and Specifications
13.5.3 Cgbio Inc. Automated Needle Targeting (ANT) Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Cgbio Inc. Main Business Overview
13.5.5 Cgbio Inc. Latest Developments
13.6 Fraunhofer IPA
13.6.1 Fraunhofer IPA Company Information
13.6.2 Fraunhofer IPA Automated Needle Targeting (ANT) Product Portfolios and Specifications
13.6.3 Fraunhofer IPA Automated Needle Targeting (ANT) Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Fraunhofer IPA Main Business Overview
13.6.5 Fraunhofer IPA Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
